Patient basic information Patient: Ms. Anastasia King) Nationality: Côte d'Ivoire Diagnosis: Cerebrospinal fluid Diagnostic hospital: Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid Cerebrospinal fluid C After the arrival of the vaccine, for the first time, the International Medical Services Team arranged multidisciplinary clinical trials (MDT) for patients, developed individualized pathways of treatment based on the patient's examination reports and physical condition, and provided translation, accompaniment and on-site services throughout the treatment process. After 13 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and various test indicators returned to normal areas, successfully reaching hospital standards.
Treatment results: Patient's final pain relief. At the time of discharge, the medical team developed a detailed return follow-up and rehabilitation plan for the patient and continued to track recovery through a remote follow-up system. 'Mrs.
Anastasia's expert comment is that this case is a typical cross-border case of suspected seriousness. The M4A relies on a multidisciplinary collaborative mechanism to develop a Chinese medicine + acupuncture + delivery program for brain water, which reflects the combined strength of Chinese hospitals in the field of suspected diagnostics and is a shorthand for the regulation of international medical services.